We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us


Thermo Fisher Scientific provides analytical instruments, lab equipment, specialty diagnostics, reagents and integrat... read more Featured Products: More products

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Handheld Mass Spectrometry Probe Identifies Clinically Relevant Bacteria

By LabMedica International staff writers
Posted on 04 Oct 2022
Print article
Image: The MasSpec Pen, a handheld mass spectrometry-based device, enables rapid analysis of biological samples, including clinically relevant bacteria (Photo courtesy of Vivian Abagiu/University of Texas)
Image: The MasSpec Pen, a handheld mass spectrometry-based device, enables rapid analysis of biological samples, including clinically relevant bacteria (Photo courtesy of Vivian Abagiu/University of Texas)

Rapid identification of bacteria is critical to prevent antimicrobial resistance and ensure positive patient outcomes. Identifying bacteria while a patient is still in surgery could allow doctors to more quickly move to a targeted antibiotic for their infection.

The Handheld Mass Spectrometry Probe consists of a handheld, disposable ionization device connected to a mass spectrometer. It works via ambient ionization, using drops of water to extract lipids and metabolites from tissue that are then analyzed via mass spectrometry to generate molecular profiles. These can be used to distinguish between different tissue types or, in the case of a recent study, different bacteria.

Medical Scientists at The University of Texas at Austin (Austin, TX, USA) and their colleagues used the MasSpec Pen (Genio Technologies, Jordan, UT, USA) on cultured samples to generate molecular profiles and develop classifiers. They analyzed 163 culture samples comprising 28 strains across eight bacterial species, including Staphylococcus aureus, Group A and B Streptococcus, and Kingella kingae. The effort focused on microorganisms commonly linked to pediatric osteoarticular infections. The system currently uses a Thermo Fisher Orbitrap Exploris 120 mass spectrometer (Thermo Fisher Scientific, Waltham MA, USA) and comes packaged as a mobile, battery-powered device that can be moved between different operating rooms.

The team then then tested these classifiers in a validation set consisting of 74 samples spanning 15 strains. In the validation work, they found that the pen was able to distinguish between Group A and B Streptococcus with 85% accuracy and between S. aureus and Staphylococcus epidermidis with 97% accuracy. The device identified a validation set of 24 samples of Gram-negative bacteria spanning six strains with accuracy of 92%. They then applied their classifiers to a set of five clinical samples taken from four patients with osteoarticular infections, exploring how the device performed in direct surgical specimens without culture. They were not able to identify the bacteria down to the species level, but were able to identify the Gram stain type and genus of the microbes in the different samples.

Livia Eberlin, PhD, associate professor of surgery and inventor of the MasSpec Pen, said, “We're centered in surgical applications, and one of the things we've been asked by a variety of surgeons, especially infectious disease surgeons, is whether we could identify bacteria when we were excising, for instance, infected bone.”

The authors concluded that the MasSpec Pen enables identification of several bacteria at different taxonomic levels in seconds from cultured samples and has potential for culture-independent identification of bacteria directly from clinical samples based on the detection of metabolic species. The study was published on September 14, 2022 in the journal Clinical Chemistry.

Related Links:
The University of Texas at Austin 
Genio Technologies 
Thermo Fisher Scientific 

Gold Supplier
Colon Cancer Mutation Panel
UltraSEEK Colon Panel
Semi-Auto Rotary Microtome
Hematology Reagents
Hematology Reagents
Thrombosis Viscoelasic Analysis System

Print article


Clinical Chem.

view channel
Image: Brief schematic diagram of the detection principle and method (Photo courtesy of CAS)

Rapid, Non-Invasive Method Diagnoses Type 2 Diabetes by Sniffing Urinary Acetone

Over 90% of diabetes cases are attributed to Type 2 diabetes (T2D), a prevalent metabolic condition that is expected to impact 380 million individuals globally by 2025. Despite being highly accurate, the... Read more

Molecular Diagnostics

view channel
Image: Researchers have identified the origin of subset of autoantibodies that worsen lupus (Photo courtesy of Pexels)

Lupus Biomarker Testing Could Help Identify Patients That Need Early and Aggressive Treatment

Systemic lupus erythematosus (SLE) is an autoimmune disease that occurs when the body's antibodies, which usually protect against infections, attack healthy cells and proteins. These autoantibodies can... Read more


view channel
Image: A genetic test could guide the use of cancer chemotherapy (Photo courtesy of Pexels)

Genetic Test Predicts Whether Bowel Cancer Patients Can Benefit From Chemotherapy

Late-stage bowel cancer patients usually undergo a series of chemotherapies and targeted medicines for cancer treatment. However, the responses to the last-line chemotherapy treatment trifluridine/tipiracil... Read more


view channel
Image: Use of DBS samples can break barriers in hepatitis C diagnosis and treatment for populations at risk (Photo courtesy of Pexels)

DBS-Based Assay Effective in Hepatitis C Diagnosis and Treatment for At Risk Populations

In a bid to eliminate viral hepatitis as a public health threat by 2030, the World Health Organization (WHO) has put forth a proposed strategy. To this end, researchers at the Germans Trias i Pujol Research... Read more


view channel
Image: New research has opened a path for fast and accurate cancer diagnosis (Photo courtesy of Imagene)

AI-Based Image Analysis Software Profiles Cancer Biomarkers in Real Time

Lung cancer is the most widespread type of cancer worldwide, resulting in approximately 1.76 million fatalities annually. Non-small cell lung cancer (NSCLC) accounts for 85% of all lung cancer diagnoses... Read more


view channel
Image: The global antimicrobial resistance diagnostics market size is expected to reach USD 5.7 billion by 2028 (Photo courtesy of Pexels)

Global Antimicrobial Resistance Diagnostics Market Driven by Increasing Hospital-Acquired Infections

Antimicrobial drugs are intended to counteract the harmful effects of microbes and promote a healthy life. However, their excessive use can result in the development of resistance, commonly referred to... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.